microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Capecitabine|DRUG: Trastuzumab
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Collaborators: Sun Yat-sen University|Huiping Li,M.D., Ph.D.,Peking University Cancer Hospital